210 related articles for article (PubMed ID: 26648661)
1. 3,5,4'-Tri-O-acetylresveratrol Attenuates Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome via MAPK/SIRT1 Pathway.
Ma L; Zhao Y; Wang R; Chen T; Li W; Nan Y; Liu X; Jin F
Mediators Inflamm; 2015; 2015():143074. PubMed ID: 26648661
[TBL] [Abstract][Full Text] [Related]
2. Hydroxytyrosol Attenuates LPS-Induced Acute Lung Injury in Mice by Regulating Autophagy and Sirtuin Expression.
Yang X; Jing T; Li Y; He Y; Zhang W; Wang B; Xiao Y; Wang W; Zhang J; Wei J; Lin R
Curr Mol Med; 2017; 17(2):149-159. PubMed ID: 28429673
[TBL] [Abstract][Full Text] [Related]
3. Schisantherin A protects lipopolysaccharide-induced acute respiratory distress syndrome in mice through inhibiting NF-κB and MAPKs signaling pathways.
Zhou E; Li Y; Wei Z; Fu Y; Lei H; Zhang N; Yang Z; Xie G
Int Immunopharmacol; 2014 Sep; 22(1):133-40. PubMed ID: 24975658
[TBL] [Abstract][Full Text] [Related]
4. 3,5,4'-Tri-O-acetylresveratrol attenuates seawater inhalation-induced acute respiratory distress syndrome via thioredoxin 1 pathway.
Zhao Y; Ma L; Wang R; Chen T; Liu X; Jin F
Int J Mol Med; 2018 Jun; 41(6):3493-3500. PubMed ID: 29512754
[TBL] [Abstract][Full Text] [Related]
5. Metformin relieves acute respiratory distress syndrome by reducing miR-138 expression.
Yu LL; Zhu M; Huang Y; Zhao YM; Wen JJ; Yang XJ; Wu P
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5355-5363. PubMed ID: 30178862
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment of ferulic acid attenuates inflammation and oxidative stress in a rat model of lipopolysaccharide-induced acute respiratory distress syndrome.
Zhang S; Wang P; Zhao P; Wang D; Zhang Y; Wang J; Chen L; Guo W; Gao H; Jiao Y
Int J Immunopathol Pharmacol; 2018; 32():394632017750518. PubMed ID: 29350567
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of c-Jun N-terminal Kinase Signaling Pathway Alleviates Lipopolysaccharide-induced Acute Respiratory Distress Syndrome in Rats.
Lai JB; Qiu CF; Chen CX; Chen MY; Chen J; Guan XD; Ouyang B
Chin Med J (Engl); 2016 Jul; 129(14):1719-24. PubMed ID: 27411461
[TBL] [Abstract][Full Text] [Related]
8. Decitabine and 5-azacitidine both alleviate LPS induced ARDS through anti-inflammatory/antioxidant activity and protection of glycocalyx and inhibition of MAPK pathways in mice.
Huang X; Kong G; Li Y; Zhu W; Xu H; Zhang X; Li J; Wang L; Zhang Z; Wu Y; Liu X; Wang X
Biomed Pharmacother; 2016 Dec; 84():447-453. PubMed ID: 27685787
[TBL] [Abstract][Full Text] [Related]
9. [Vaspin protects against lipopolysaccharide-induced acute respiratory distress syndrome in mice by inhibiting inflammation and protecting vascular endothelium via PI3K/Akt signal pathway].
Li W; Qi D; Chen L; Zhao Y; Deng W; Tang XM; Wang DX
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Mar; 38(3):283-288. PubMed ID: 29643033
[TBL] [Abstract][Full Text] [Related]
10. Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro.
Jing W; Chunhua M; Shumin W
Toxicol Appl Pharmacol; 2015 Jun; 285(2):128-35. PubMed ID: 25902336
[TBL] [Abstract][Full Text] [Related]
11. Astilbin alleviates LPS-induced ARDS by suppressing MAPK signaling pathway and protecting pulmonary endothelial glycocalyx.
Kong G; Huang X; Wang L; Li Y; Sun T; Han S; Zhu W; Ma M; Xu H; Li J; Zhang X; Liu X; Wang X
Int Immunopharmacol; 2016 Jul; 36():51-58. PubMed ID: 27111514
[TBL] [Abstract][Full Text] [Related]
12. Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-κB activation in acute lung injury mice.
Zhong WT; Wu YC; Xie XX; Zhou X; Wei MM; Soromou LW; Ci XX; Wang DC
Fitoterapia; 2013 Oct; 90():132-9. PubMed ID: 23751215
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment with olprinone hydrochloride, a phosphodiesterase III inhibitor, attenuates lipopolysaccharide-induced lung injury via an anti-inflammatory effect.
Koike T; Nadeen Qutab M; Tsuchida M; Takekubo M; Saito M; Hayashi J
Pulm Pharmacol Ther; 2008; 21(1):166-71. PubMed ID: 17434327
[TBL] [Abstract][Full Text] [Related]
14. p38MAPK inhibition attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway.
Liu S; Feng G; Wang GL; Liu GJ
Eur J Pharmacol; 2008 Apr; 584(1):159-65. PubMed ID: 18328478
[TBL] [Abstract][Full Text] [Related]
15. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
Feng G; Sun B; Li TZ
Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
[TBL] [Abstract][Full Text] [Related]
16. Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice.
Chen X; Yang X; Liu T; Guan M; Feng X; Dong W; Chu X; Liu J; Tian X; Ci X; Li H; Wei J; Deng Y; Deng X; Chi G; Sun Z
Int Immunopharmacol; 2012 Oct; 14(2):209-16. PubMed ID: 22835426
[TBL] [Abstract][Full Text] [Related]
17. Ulinastatin attenuates pulmonary endothelial glycocalyx damage and inhibits endothelial heparanase activity in LPS-induced ARDS.
Wang L; Huang X; Kong G; Xu H; Li J; Hao D; Wang T; Han S; Han C; Sun Y; Liu X; Wang X
Biochem Biophys Res Commun; 2016 Sep; 478(2):669-75. PubMed ID: 27498004
[TBL] [Abstract][Full Text] [Related]
18. Oxidized phospholipids reduce vascular leak and inflammation in rat model of acute lung injury.
Nonas S; Miller I; Kawkitinarong K; Chatchavalvanich S; Gorshkova I; Bochkov VN; Leitinger N; Natarajan V; Garcia JG; Birukov KG
Am J Respir Crit Care Med; 2006 May; 173(10):1130-8. PubMed ID: 16514111
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine attenuates acute lung injury induced by lipopolysaccharide in mouse through inhibition of MAPK pathway.
Xu Y; Zhang R; Li C; Yin X; Lv C; Wang Y; Zhao W; Zhang X
Fundam Clin Pharmacol; 2015 Oct; 29(5):462-71. PubMed ID: 26211495
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury.
Zhang Y; Liang D; Dong L; Ge X; Xu F; Chen W; Dai Y; Li H; Zou P; Yang S; Liang G
Respir Res; 2015 Mar; 16(1):43. PubMed ID: 25889862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
